LINK WILLIAM J PHD
Transaction: 06/25/2026
BUY
Change
+806
Price
Not reported
Filing
06/29/2026
Type
BUY
Tarsus Pharmaceuticals, Inc.
TARS • Biotechnology
$90.78
▲ +7.58 (+9.10%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.94B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 40.5%Manageable debt level · 0.27Healthy liquidity · 3.85Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:54 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$90.78
Change9.10%
Shares Out43.39M
Market Cap$3.94B
Enterprise Value$3.49B
52W Range44.67 - 85.25
Beta0.50
P/E-84.76
P/S6.50
P/B11.36
P/FCF70.34
EV/Sales5.76
Price$90.78
Change9.10%
Shares Out43.39M
Market Cap$3.94B
Enterprise Value$3.49B
52W Range44.67 - 85.25
Beta0.50
P/E-84.76
P/S6.50
P/B11.36
P/FCF70.34
EV/Sales5.76
EV/EBITDA-84.34
EV/FCF62.31
Earnings Yield-1.18%
FCF Yield1.42%
Dividend Yield0.00%
Gross Margin93.20%
Oper. Margin-15.72%
Profit Margin-14.72%
Debt/Eq0.27
Current Ratio3.85
Quick Ratio3.82
Target$95.67
Target Upside5.39%
Target Median$98.00
Target Range89.00 - 100.00
Volume1.65M
Avg Volume971.00K
EPS Surprise0.24
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
30/100
Why this score▼
Positive revenue growth · 40.5%Manageable debt level · 0.27Healthy liquidity · 3.85Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
95/100
Bullish
Bullish
9
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$89.00
Mean
$93.50
Median
$93.50
High
$98.00
Insider Transactions
Recent executive and insider activity
LINK WILLIAM J PHD
Transaction: 06/25/2026
BUY
Change
+3,837
Price
$64.34
Filing
06/29/2026
Type
BUY
PYOTT DAVID E I
Transaction: 06/25/2026
BUY
Change
+806
Price
Not reported
Filing
06/29/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| LINK WILLIAM J PHD | BUY | +806 | Not reported | 06/25/2026 | 06/29/2026 |
| LINK WILLIAM J PHD | BUY | +3,837 | $64.34 | 06/25/2026 | 06/29/2026 |
| PYOTT DAVID E I | BUY | +806 | Not reported | 06/25/2026 | 06/29/2026 |
| PYOTT DAVID E I | BUY | +3,837 | $64.34 | 06/25/2026 | 06/29/2026 |
| YARNO WENDY L | BUY | +1,209 | Not reported | 06/25/2026 | 06/29/2026 |
| YARNO WENDY L | BUY | +3,837 | $64.34 | 06/25/2026 | 06/29/2026 |
| CHAUDHURI BHASKAR | BUY | +2,417 | Not reported | 06/25/2026 | 06/29/2026 |
| CHAUDHURI BHASKAR | BUY | +3,837 | $64.34 | 06/25/2026 | 06/29/2026 |
| Morrison Scott W | BUY | +2,417 | Not reported | 06/25/2026 | 06/29/2026 |
| Morrison Scott W | BUY | +3,837 | $64.34 | 06/25/2026 | 06/29/2026 |
| Goldberg Andrew D. | BUY | +2,417 | Not reported | 06/25/2026 | 06/29/2026 |
| Goldberg Andrew D. | BUY | +3,837 | $64.34 | 06/25/2026 | 06/29/2026 |
| Goodrich Katherine | BUY | +2,417 | Not reported | 06/25/2026 | 06/29/2026 |
| Goodrich Katherine | BUY | +3,837 | $64.34 | 06/25/2026 | 06/29/2026 |
| Azamian Bobak R. | SELL | -5,418 | $61.81 | 06/17/2026 | 06/22/2026 |
| Farrow Jeffrey S | SELL | -14,396 | $60.95 | 06/16/2026 | 06/17/2026 |
| LINK WILLIAM J PHD | SELL | -1,928 | $62.94 | 06/15/2026 | 06/17/2026 |
| Goodrich Katherine | SELL | -2,954 | $62.08 | 06/15/2026 | 06/17/2026 |
| Farrow Jeffrey S | SELL | -27,881 | Not reported | 06/15/2026 | 06/17/2026 |
| Farrow Jeffrey S | BUY | +27,881 | Not reported | 06/15/2026 | 06/17/2026 |